共 26 条
- [1] Hawe P., Shiell A., Preserving innovation under increasing accountability pressures: The health promotion investment portfolio approach, Health Promotion J Aust, 5, pp. 4-9, (1995)
- [2] Bridges J., Van Gool K., King M., A cost-effectiveness analysis of nutrition interventions: First steps towards applying portfolio theory in public health, Economics and Health: 1999. Proceedings of the Twentieth Australian Conference of Health Economists, Australian Studies in Health Service Administration, 87, pp. 111-125, (2000)
- [3] O'Brien B., Sculpher M., Building uncertainty into cost-effectiveness rankings: Portfolio risk-return trade-offs and implications for decision rules, Med Care, 38, pp. 460-468, (2000)
- [4] Drummond M., O'Brien B., Stoddart G., Torrance G., Methods for the Economic Evaluation of Health Care Programmes, 2nd Edn., (1997)
- [5] Gold M., Siegel J., Russell L., Weinstein M., Cost-effectiveness in Health and Medicine, (1996)
- [6] Lavori P., Dawson R., Developing and comparing treatment strategies: An annotated portfolio of design, Psychopharmacol Bull, 34, pp. 13-18, (1998)
- [7] Kindig D., Purchasing population health: Aligning financial incentives to improving health outcome, Health Services Res, 33, pp. 223-242, (1988)
- [8] Allardice G., McMenamin J., Parpia T., Gibbs J., McSharry C., Whitelaw J., The recent impact of antiretroviral therapy on CD4 counts, AIDS and death in HIV-infected persons: Routine HIV surveillance in Scotland, Int J STD AIDS, 9, pp. 561-566, (1998)
- [9] Gurfinkel E., Manos E., Mejail R., Cerda M., Duronto E., Garcia C., Daroca A., Mautner B., Low molecular weight aspirin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia, J Am Coll Cardiol, 26, pp. 313-318, (1995)
- [10] Kok G., Hopsers H., Den Boer D., De Vries H., Health education at the individual level, Behavioural Medicine Approaches to Cardiovascular Disease Prevention, (1996)